1. Home
  2. PFS vs BCRX Comparison

PFS vs BCRX Comparison

Compare PFS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Services Inc

PFS

Provident Financial Services Inc

HOLD

Current Price

$22.10

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.08

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFS
BCRX
Founded
1839
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
PFS
BCRX
Price
$22.10
$9.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$23.75
$20.82
AVG Volume (30 Days)
753.0K
4.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
4.28%
N/A
EPS Growth
112.38
381.40
EPS
0.61
N/A
Revenue
$73,109,000.00
$25,186,000.00
Revenue This Year
$0.68
N/A
Revenue Next Year
$5.97
$12.55
P/E Ratio
$36.21
N/A
Revenue Growth
7.06
N/A
52 Week Low
$15.92
$6.00
52 Week High
$23.98
$11.31

Technical Indicators

Market Signals
Indicator
PFS
BCRX
Relative Strength Index (RSI) 49.73 52.69
Support Level $21.53 $8.89
Resistance Level $22.96 $9.73
Average True Range (ATR) 0.41 0.43
MACD -0.00 0.00
Stochastic Oscillator 61.60 56.43

Price Performance

Historical Comparison
PFS
BCRX

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: